Atarax Related Published Studies
Well-designed clinical trials related to Atarax (Hydroxyzine)
Short-term effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy volunteers. [2011.06]
[Effects of hydroxyzine on tolerance of facial mask during induction in children] [2010.01]
Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments. [2008.12]
Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs. [2008.12]
Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. [2007.04]
[Hydroxyzine premedication does not alter bispectral index changes following etomidate induction of general anaesthesia] [2007.03]
Histamine H1 Blocker Hydroxyzine Improves Sleep in Patients With Cirrhosis and Minimal Hepatic Encephalopathy: A Randomized Controlled Pilot Trial. [2007.01.11]
Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. [2007]
A prospective study of 2 sedation regimens in children: chloral hydrate, meperidine, and hydroxyzine versus midazolam, meperidine, and hydroxyzine. [2006.09]
Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers. [2006.01]
Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. [2005.10]
A comparison of two meperidine/hydroxyzine sedation regimens for the uncooperative pediatric dental patient. [2005.09]
Well-designed clinical trials possibly related to Atarax (Hydroxyzine)
Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen season. [2011.04]
Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands. [2011.03]
A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus. [2011.03]
Pharmacokinetics and effects of cetirizine in horses with insect bite hypersensitivity. [2011.03]
Anti-inflammatory activity and clinical efficacy of a 3-month levocetirizine therapy in mite-allergic children. [2011.02]
Determination of cetirizine in human plasma using high performance liquid chromatography coupled with tandem mass spectrometric detection: application to a bioequivalence study. [2011]
Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects
with perennial allergic rhinitis. [2011]
Use of montelukast alone or in combination with desloratadine or levocetirizine
in patients with persistent allergic rhinitis. [2011]
Anti-inflammatory activity and clinical efficacy of a 3-month levocetirizine
therapy in mite-allergic children. [2011]
Efficacy and safety of montelukast add-on therapy in allergic rhinitis. [2010.11]
Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety. [2010.08]
Clinical observation on the treatment of chronic urticaria with total glucosides of paeony capsule combined with citirizine. [2010.08]
Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria. [2010.07]
Efficacy and safety of modified sequential three-step empirical therapy for chronic cough. [2010.07]
Study of levocetirizine in seasonal allergic rhinitis. [2010.06]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. [2010.05]
The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures. [2010.05]
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study. [2010.04]
Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study. [2010.03]
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. [2010.03]
Clinical assessment of levocetirizine and budesonide in treatment of persistent allergic rhinitis regarding to symptom severity. [2010.02]
Gabapentin premedication: assessment of preoperative anxiolysis and postoperative patient satisfaction. [2010]
Safety and tolerability of levocetirizine dihydrochloride in infants and children
with allergic rhinitis or chronic urticaria. [2010]
Efficacy and safety of levocetirizine in improving symptoms and health-related
quality of life in US adults with seasonal allergic rhinitis: a randomized,
placebo-controlled study. [2010]
Study of levocetirizine in seasonal allergic rhinitis. [2010]
The effectiveness of levocetirizine and desloratadine in up to 4 times
conventional doses in difficult-to-treat urticaria. [2010]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on
allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in
the Vienna Challenge Chamber. [2010]
The effects of single dose anxiolytic medication on the CO2 models of anxiety:
differentiation of subjective and objective measures. [2010]
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis. [2009.11]
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study. [2009.09]
IL13 variants are associated with total serum IgE and early sensitization to food allergens in children with atopic dermatitis. [2009.09]
The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis. [2009.08]
Experience with cyclosporine in children with chronic idiopathic urticaria. [2009.07]
Treatment of chronic idiopathic urticaria with levamisole: a multicentre, randomized, double-blind, controlled trial. [2009.07]
Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines. [2009.06]
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. [2009.04]
Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis. [2009.03]
A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis. [2009.02]
Pharmacokinetics and bioequivalence study of two cetirizine hydrochloride formulations in healthy Chinese male volunteers. [2009]
Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. [2009]
Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy. [2008.11]
Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study. [2008.10]
Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients. [2008.09]
Fexofenadine effects on cognitive performance in aviators at ground level and simulated altitude. [2008.08]
A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. [2008.07]
Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis. [2008.07]
[Dishen Qufeng Decoction for treating allergic rhinitis: a randomized controlled trial.] [2008.07]
Comparative bioavailability of two cetirizine tablet formulations in Indonesian healthy volunteers. [2008.05]
Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the Environmental Exposure Unit. [2008.05]
Determination of levocetirizine in human plasma by liquid chromatography-electrospray tandem mass spectrometry: application to a bioequivalence study. [2008.02.01]
Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. [2008.02]
Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial. [2008]
Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. [2008]
Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. [2007.11]
Safety of levocetirizine treatment in young atopic children: An 18-month study. [2007.09]
H1-antihistamine treatment in young atopic children: effect on urticaria. [2007.09]
The effect of antihistamine cetirizine on ventricular repolarization in congenital long QT syndrome. [2007.07]
Comparison of antileukotrienes and antihistamines in the treatment of allergic rhinitis. [2007.07]
Efficacy of montelukast for treating perennial allergic rhinitis. [2007.05]
Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis. [2007.04]
Combined mediator blockade or topical steroid for treating the unified allergic airway. [2007.01]
Construction of an environmental exposure unit and investigation of the effects of cetirizine hydrochloride on symptoms of cedar pollinosis in Japan. [2007]
Study of the EEG changes during the combined ingestion of alcohol and H1-antihistamines by using the wavelet transform. [2007]
[Does new antihistamines characterize tachyphylaxis phenomenon?] [2007]
Paederus dermatitis in Sierra Leone. [2006.12.10]
Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. [2006.11]
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial] [2006.11]
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial] [2006.11]
Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. [2006.10]
Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study. [2006.09]
Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. [2006.09]
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. [2006.09]
Facial thermography is a sensitive tool to determine antihistaminic activity: comparison of levocetirizine and fexofenadine. [2006.08]
A randomized controlled trial of cetirizine plus pseudoephedrine versus loratadine plus pseudoephedrine for perennial allergic rhinitis. [2006.06]
A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. [2006.06]
Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. [2006.05]
Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. [2006.04]
Severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiency: first case presentation showing competition for excretion via renal multidrug resistance protein 1 and organic cation transporter 2. [2006.04]
Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. [2006.03]
Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses. [2006.02]
Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. [2006.02]
Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. [2006.01]
Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. [2006]
Maximum skin hyperaemia induced by local heating: possible mechanisms. [2006]
Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria. A randomized, double-blind, placebo-controlled pilot study. [2006]
Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. [2005.12]
A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis. [2005.10]
Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD). [2005.10]
Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. [2005.08]
|
